InterCure Ltd.
INCR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $65 | $65 | $57 | $57 |
| % Growth | 0% | 14.9% | 0% | – |
| Cost of Goods Sold | $45 | $45 | $56 | $56 |
| Gross Profit | $20 | $20 | $0 | $0 |
| % Margin | 30.9% | 30.9% | 0.3% | 0.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7 | $7 | $18 | $18 |
| SG&A Expenses | $21 | $21 | $32 | $32 |
| Sales & Mktg Exp. | $13 | $13 | $13 | $13 |
| Other Operating Expenses | -$3 | -$3 | $7 | $7 |
| Operating Expenses | $17 | $17 | $39 | $39 |
| Operating Income | $3 | $3 | -$39 | -$39 |
| % Margin | 4.4% | 4.4% | -68.7% | -68.7% |
| Other Income/Exp. Net | $0 | $0 | -$6 | -$6 |
| Pre-Tax Income | -$1 | -$1 | -$44 | -$44 |
| Tax Expense | $0 | $0 | -$8 | -$8 |
| Net Income | -$1 | -$1 | -$35 | -$35 |
| % Margin | -1.3% | -1.3% | -61.2% | -61.2% |
| EPS | -0.015 | -0.015 | -0.79 | -0.79 |
| % Growth | 0% | 98.1% | 0% | – |
| EPS Diluted | -0.015 | -0.015 | -0.79 | -0.79 |
| Weighted Avg Shares Out | 57 | 57 | 44 | 44 |
| Weighted Avg Shares Out Dil | 57 | 57 | 44 | 44 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $4 | $4 |
| Depreciation & Amortization | $4 | $4 | $2 | $2 |
| EBITDA | $7 | $7 | -$47 | -$47 |
| % Margin | 11% | 11% | -82.5% | -83.2% |